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Abstract
Growth hormone (GH)-transgenic mice with permanently elevated systemic
levels of GH and insulin-like growth factor 1 (IGF1) reproducibly develop
renal and glomerular hypertrophy and subsequent progressive glomeruloscle-
rosis, finally leading to terminal renal failure. To dissociate IGF1-dependent
and -independent effects of GH excess on renal growth and lesion develop-
ment in vivo, the kidneys of 75 days old IGF1-deficient (I/) and of IGF1-
deficient GH-transgenic mice (I//G), as well as of GH-transgenic (G) and
nontransgenic wild-type control mice (I+/+) were examined by quantitative
stereological and functional analyses. Both G and I//G mice developed
glomerular hypertrophy, hyperplasia of glomerular mesangial and endothelial
cells, podocyte hypertrophy and foot process effacement, albuminuria, and
glomerulosclerosis. However, I//G mice exhibited less severe glomerular
alterations, as compared to G mice. Compared to I+/+ mice, G mice exhibited
renal hypertrophy with a significant increase in the number without a change
in the size of proximal tubular epithelial (PTE) cells. In contrast, I//G mice
did not display significant PTE cell hyperplasia, as compared to I/ mice.
These findings indicate that GH excess stimulates glomerular growth and
induces lesions progressing to glomerulosclerosis in the absence of IGF1. In
contrast, IGF1 represents an important mediator of GH-dependent proximal
tubular growth in GH-transgenic mice.
Introduction
During the last decades, a significant role of the growth
hormone (GH) and insulin-like growth factor 1 (IGF1)
system in kidney development and function, and in the
pathogenesis of chronic kidney diseases (CKD) and their
sequelae, has become apparent (Wolf et al. 2000; Schri-
jvers et al. 2004; Mak et al. 2008; Kumar et al. 2011;
Kamenicky et al. 2014; Bach and Hale 2015). In differ-
ent entities of CKD, including diabetic nephropathy
(DN), progressive glomerulosclerosis is the common
histopathological feature, and is regarded as the deter-
mining mechanism driving the progressive loss of func-
tioning nephrons and subsequent renal scarring, finally
leading to terminal renal failure (Klahr et al. 1988; Fogo
and Ichikawa 1989, 1991; el Nahas 1989). There is
strong evidence for an involvement of the GH/IGF1 axis
in induction, maintenance, and progression of glomeru-
lar and podocyte hypertrophy and damage, which repre-
sent the pathogenetic key lesions triggering development
of progressive glomerulosclerosis (Fogo and Ichikawa
1991; Wanke et al. 2001; Kriz 2002; Pavenstadt et al.
2003; Reddy et al. 2007; Kumar et al. 2011). The pro-
ceeding enlargement of glomeruli and podocytes induces
a characteristic sequence of alterations, finally leading
to obsolescence of the glomerulus, atrophy of the
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corresponding nephron, and subsequent tubulointerstitial
lesions (Fogo and Ichikawa 1991; Wiggins 2007).
Glomerular hypertrophy is characterized by increased
numbers of glomerular mesangial and endothelial cells
and is commonly associated with increased matrix depo-
sition in the glomerular mesangium (Schrijvers et al.
2004; Thrailkill et al. 2009). Unlike mesangial and
endothelial cells, visceral epithelial glomerular cells
(podocytes) are postmitotically fixed and therefore not
capable of hyperplastic growth responses (Kriz 1996;
Wanke et al. 2001; Wiggins 2007). Along with the pro-
gressive enlargement of the glomerular volume, the
mean podocyte volume increases and a characteristic
sequence of podocyte alterations subsequently develops,
including podocyte foot process effacement, impairment
of the glomerular filtration barrier, albuminuria, detach-
ment of podocytes from the glomerular basement mem-
brane (GBM), synechia formation between the capsule
of Bowman and denuded GBM areas of the glomerular
tuft, capillary and extracapillary hyalinosis, collapse of
glomerular capillaries, and misdirected filtration into the
periglomerular interstitium with subsequent inflamma-
tory and fibrotic tubulointerstitial lesions and atrophy of
nephrons (Kretzler et al. 1994; Kriz 1996, 2002, 2012;
Kriz et al. 1996; Wanke et al. 2001; Kriz and LeHir
2005; Wiggins 2007). Much of our understanding and
knowledge of the pathogenetically relevant processes in
development of glomerulosclerosis was gained by study-
ing the nephropathy of GH-transgenic mice (Doi et al.
1988, 1990; Wanke et al. 1991, 2001; Wolf et al. 1993;
Yang et al. 1993; von Waldthausen et al. 2008). GH-
transgenic mice exhibit permanently elevated systemic
concentrations of GH and IGF1. They display a typical
spectrum of GH excess associated alterations, such as
disproportionately stimulated body and organ growth
(Wanke et al. 1991, 1992; Le Roith et al. 2001) and
diverse characteristic organ lesions (Doi et al. 1990;
Wanke et al. 1991, 1992, 2001; Stefaneanu et al. 1993;
Wolf et al. 1993; Wolf and Wanke 1997; Dirsch et al.
1998; Miquet et al. 2008; Blutke et al. 2014). In the kid-
neys, GH-transgenic mice reproducibly develop the full
spectrum of the lesions delineated above, from induc-
tion of overall renal growth and glomerular hypertrophy
to age-related development of progressive glomeruloscle-
rosis and tubulointerstitial lesions, finally leading to ter-
minal renal failure (end-stage renal disease) (Wanke
et al. 1991, 2001; Wolf et al. 1993). However, the exact
roles of excess GH and of subsequently elevated IGF1 in
stimulation of renal and glomerular growth in GH-
transgenic mice are yet not completely clarified. Since
GH-transgenic mice have been and will continue to be
used as valuable models enabling the study of diverse
aspects of different human nephropathies, including the
essential involvement of the GH/IGF1 axis in the devel-
opment of glomerulosclerotic alterations (Reddy et al.
2007; Kumar et al. 2010, 2011; Grunenwald et al. 2011)
and the testing of new therapeutic strategies, it is of
crucial importance to further improve the understanding
of the contribution of single factors of the GH/IGF1
axis to the pathomechanisms underlying the nephropa-
thy in the model of the GH-transgenic mouse. There-
fore, the present study used a unique collective of
IGF1-deficient GH-transgenic mice (I//G) (Blutke
et al. 2014) to dissociate IGF1-dependent and IGF1-
independent excess GH-stimulated morphologic growth
effects on different renal compartments, nephron struc-




I//G IGF1-deficient, GH-transgenic mice
I+/ Heterozygous IGF1-deficient mice
I+//G Heterozygous IGF1-deficient, GH-transgenic mice
I+/+ Wild-type control mice
G GH-transgenic mice
Analysis techniques, reagents, and
histological stains
TEM Transmission electron microscopy
GMA/MMA Glycolmethacrylate/methylmethacrylate
HE Hematoxylin and eosin
PAS Periodic acid Schiff
PASM Periodic acid silver methenamine
Abbreviations of anatomical structures used
in stereological terms
Kid Kidney
OSM Outer stripe of the medulla
ISM/IZM Inner stripe and inner zone of medulla
PT Proximal tubules
OT Other tubules
PTE Proximal tubular epithelium
Pod Podocyte
Glom Glomerulus
GBM Glomerular basement membrane
Cap Capillary
Weight and density
KW Weight of both kidneys (mm³)
q(Kid) Kidney density (mg/mm³)
2016 | Vol. 4 | Iss. 5 | e12709
Page 2
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Excess GH and IGF1 Effects on Renal Growth A. Blutke et al.
Morphometrical and quantitative
stereological parameters
Volume densities (fractional volumes)
VV(Cortex/Kid) Volume density of the renal
cortex in the kidneys
v/v
VV(OSM/Kid) Volume density of the OSM
in the kidneys
v/v
VV(ISM/IZM/Kid) Volume density of the ISM/
IZM in the kidneys
v/v
VV(Glom/Cortex) Volume density of the
glomeruli in the renal cortex
v/v
VV(Pod/Glom) Volume density of podocytes
in the glomeruli
v/v
VV(Cap/Glom) Volume density of capillaries
in the glomeruli
v/v
VV(Mes/Glom) Volume density of the
mesangium in the glomeruli
v/v
VV(PT/Cortex+OSM) Volume density of PT in the
renal cortex and the OSM
v/v
VV(OT/Cortex+OSM) Volume density of OT in the
renal cortex and the OSM
v/v
VV(PTE/Cortex+OSM) Volume density of the PTE in
the renal cortex and the
OSM
v/v
fs Linear tissue shrinkage factor;
fs = 0.91 for GMA/MMA-,




V(Kid) Volume of both kidneys (mm³)
V(Cortex, Kid) Volume of the renal
cortex in both kidneys
(mm³)
V(OSM, Kid) Volume of the OSM in
both kidneys
(mm³)
V(Cortex+OSM, Kid) Volume of the renal
cortex and the OSM in
both kidneys
(mm³)
V(ISM/IZM, Kid) Volume of the ISM/IZM
in both kidneys
(mm³)
V(PT, Cortex+OSM) Volume of the PT in the
renal cortex and the
OSM in both kidneys
(mm³)
V(OT, Cortex+OSM) Volume of OT in the
renal cortex and the
OSM in both kidneys
(mm³)
V(PTE, Cortex+OSM) Total PTE volume in the
renal cortex and the
OSM in both kidneys
(mm³)
V(Glom, Cortex) Volume of all glomeruli
in the renal cortex in
both kidneys
(mm³)




v(Glom) Mean glomerular volume (10³ lm³)
v(Glom)/BW Mean glomerular volume
relative to body weight
(103
lm³/g)
v(Glom)/KW Mean glomerular volume




Mean volume of PTE
cells in the cortex and
OSM
(10³ lm³)
v(Pod) Mean podocyte volume (lm³)
v(Cap, Glom) Mean capillary volume
per glomerulus
(10³ lm³)
v(Mes, Glom) Mean mesangial volume
per glomerulus
(10³ lm³)





NV(Glom/Kid) Numerical volume density of





Numerical density of PTE
cells in the renal cortex
(n/103 lm³)
NV(C/Glom) Numerical volume density of
glomerular cells in the
glomeruli
(n/105 lm³)
NV(M-E/Glom) Numerical volume density of
mesangial and endothelial
cells in the glomeruli
(n/105 lm³)
NV(Pod/Glom) Numerical volume density of
podocytes in the glomeruli
(n/105 lm³)
Total numbers




Total number of PTE cells in the renal
cortex and the OSM of both kidneys
N(Pod, Kid) Total number of podocytes in all
glomeruli of in both kidneys
N(C, Glom) Mean number of glomerular cells per
glomerulus
N(M-E, Glom) Mean number of glomerular mesangial
and endothelial cells per glomerulus
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2016 | Vol. 4 | Iss. 5 | e12709
Page 3
A. Blutke et al. Excess GH and IGF1 Effects on Renal Growth
N(Pod, Glom) Mean number of podocytes per
glomerulus
Length densities and lengths
LV(Cap/Glom) Length density of capillaries
per glomerulus
(m/mm³)
L(Cap, Glom) Average length of the
capillaries in one glomerulus
(mm)
L(Glom-cap, Kid) Total length of glomerular






Filtration slit frequency (n/mm)
Th(GBM) The true harmonic mean
thickness of the GBM
(nm)
lh(GBM) Apparent harmonic mean




VV(X/Y) = AA(X/Y) = ∑A(X)/∑A(Y) = ∑Pt(X)/∑Pt(Y)
= PtPt(X/Y)
VV(X/Y) Volume density of the structure X in the
reference compartment Y
AA(X/Y) Area density of the structure X in the
reference compartment Y
∑A(X)/∑A(Y) Quotient of the cumulative section area of
the structure X in all examined kidney
sections per case and the cumulative
section area of the reference
compartment Y in the same sections
∑Pt(X)/∑Pt(Y) Quotient of the total number of points
hitting section profiles of the structure X
in all examined sections per case and the
total number of points hitting the
reference compartment Y in the same
sections
PtPt(X/Y) Point density of the structure X in the
reference compartment Y
Volumes
V(X, Y) = VV(X/Y) 9 V(Y)
V(X, Y) Total volume of the structure X in the reference
compartment Y
VV(X/Y) Volume density of the structure X in the
reference compartment Y





(X)/h 9 ∑A(Y)) 9 fs³
NV(X/Y) Numerical volume density of elements of the
structure X in the reference compartment Y
∑Q(X) Cumulative number of all counted elements
(Q) of the structure X in all examined
disectors per case
h Disector height, that is, distance between the
reference and the “look-up” section
∑A(Y) Cumulative area of the reference compartment
sections in all examined disectors per case
(for each disector, the mean of the reference
compartment section areas in the reference
and the “look-up” section is used for
calculation)
h 9 ∑A(Y) Cumulative volume of all disectors examined
per case
fs Linear tissue shrinkage factor (0.91 for GMA/
MMA-, and 0.95 for Epon-embedded
murine kidney tissue)
Numbers
N(X, Y) = NV(X/Y) 9 V(Y)
N(X, Y) Number of individual elements of a distinct
structure X in the reference compartment Y
NV(X/Y) Numerical volume density of elements of the
structure X in the reference compartment Y
V(Y) Volume of the reference compartment Y
Equations–Special parameters
V(Kid) = KW/q(Kid)
v(Glom) = V(Glom, Cortex)/N(Glom, Cortex)
= VV(Glom/Cortex)/NV(Glom, Cortex)
v(Mes, Glom) = VV(Mes/Glom) 9 v(Glom)
v(Pod) = VV(Pod/Glom)/NV(Pod/Glom)
V(Pod, Glom) = v(Glom) 9 VV(Pod/Glom)
v(Cap, Glom) = VV(cap/Glom) 9 v(Glom)
V(Glom-cap, Kid) = VV(Cap/Glom) 9 V(Glom, Cortex)
L(Cap, Glom) = LV(Cap/Glom) 9 v(Glom)
L(Glom-cap, Kid) = L(Cap, Glom) 9 N(Glom, Cortex)
v(PTE cell, Cortex+OSM) = VV(PTE cells/Cortex+OSM)/
NV(PTE cells/Cortex+OSM)
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N(X, Glom) = NV(X, Glom) 9 v(Glom)
N(X, Glom) Average number of cells of type X per
glomerulus
All glomerular cell types, X = C; Mesangial
and endothelial glomerular cells, X = Mes-E;
Podocytes, X = Pod
LV(Cap/Glom) = 2 9 ΣQ(Cap)/ΣA(Glom) 9 fs
2
LV(Cap/Glom) Length density of capillaries per glomerulus
ΣQ(Cap) Number of glomerular capillary section
profiles per case
ΣA(Glom) Cumulative area of all examined glomerular
tuft section profiles
fs Linear tissue shrinkage factor
Th(GBM) = (8/3p) 9 (10
6/M) 9 lh(GBM)
Th(GBM) The true harmonic mean thickness of the GBM
M Final print magnification
lh(GBM) Apparent harmonic mean thickness of the GBM
lh(GBM) = ∑N of observations/∑(Midpoints 9
N of observations)
Materials and Methods
Ethics statement and animal housing
All experiments were approved by the author’s institutional
committee on animal care, were carried out in accordance
with the German Animal Protection Law, and conformed
to international guidelines on the ethical use of animals.
All efforts were made to minimize the number of animals
used and their suffering. All animals investigated in the
present study were maintained under specified pathogen-
free conditions in a closed barrier system on a 12:12-h
light–dark cycle and had free access to a standard rodent
diet (V1534; Ssniff, Soest, Germany) and tap water.
Mice
IGF1-deficient, GH-transgenic mice (I//G) were gener-
ated, as described in detail previously (Blutke et al. 2014).
Briefly, female heterozygous IGF1-deficient mice (I+/)
mice on NMRI outbred background (Powell-Braxton
et al. 1993; Blutke et al. 2014) were mated with male
hemizygous GH-transgenic NMRI mice (G), overexpress-
ing bovine GH under the transcriptional control of the
phosphoenolpyruvate-carboxykinase promoter (Wanke
et al. 1996; Hoeflich et al. 2002). Male I+//G offspring
were then mated with female I+/ mice to obtain the
following six genotypes: I/, I//G, I+/, I+//G, G, and
wild-type control mice (I+/+). Genotyping was performed
by PCR, as described previously (Powell-Braxton et al.
1993; Hoeflich et al. 2001; Blutke et al. 2014). Samples of
kidney tissue examined in the present study included
specimens derived from mice which had been investigated
in a previously published study on body and organ
growth and pathology of I//G mice (Blutke et al.
2014). IGF1 serum levels, detection of serum GH, and
glomerulosclerosis indices of I/, I//G, I+/, I+//G, G,
and I+/+ mice have as well been reported in this previous
study (Blutke et al. 2014).
Urine analyses
Spot urine samples were taken weekly (from week 4 to
11) between 2:00 and 3:00 PM and immediately stored at
80°C until assayed. Per week, at least five urine samples
were collected from mice of each investigated genotype
and sex. Urine creatinine concentrations were determined
using an automated analyzer technique (Hitachi, Merck,
Darmstadt, Germany). For SDS-PAGE, urine samples
were diluted to a creatinine content of 1.5 mg/dL. Urine
proteins were temperature denatured (Thermoblock TB1,
Biometra, Germany) and separated using a 12% SDS-
PAGE gel (Protean III, Bio-Rad, Munich, Germany)
together with a broad molecular weight standard (Bio-
Rad) and a mouse albumin standard (Biotrend, Cologne,
Germany), as described previously (Herbach et al. 2009).
Coomassie blue staining of gels was performed according
to a standard protocol.
Body and kidney weights, kidney processing,
histology, and electron microscopy
At 11 weeks of age, I/ (5/3), I//G (3/4), I+/ (5/5),
I+//G (5/5), I+/+ (5/5), and G (5/5) (n = male/female, if
not stated differently) mice were sacrificed. After determi-
nation of body weight (Blutke et al. 2014), mice were
killed by cervicocranial dislocation and immediately
perfused with neutrally buffered 2.5% glutaraldehyde
solution through the heart, as described previously
(Wanke et al. 2001; Herbach et al. 2009). After immer-
sion fixation in 2.5% glutaraldehyde solution, the kidneys
were removed carefully, separated from adjacent tissues,
blotted dry, and weighed to the nearest weight (mg). The
density of the glutaraldehyde-fixed kidney tissue was
determined according to the method described by Scherle
(Scherle 1970) and consistently corresponded to 1.05 g/
cm³. Next, the kidneys were cut perpendicular to the lon-
gitudinal axis (20  5 approximately 1-mm thick slices in
both kidneys), routinely processed and embedded in
plastic for light microscopy and transmission electron
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microscopy (TEM) as described previously (Hermanns
et al. 1981; Hoeflich et al. 2002). For TEM, three 1-mm³
samples of the renal cortex per animal were selected by
systematic random sampling (Nyengaard 1999), postfixed
in 1% osmium tetroxide, and routinely embedded in
Epon resin. Per case, 10 consecutive 0.5-lm thick semi-
thin sections were cut from each Epon block and stained
with toluidine blue O and safranin. For TEM, ultrathin
sections (70–80 nm) were cut, stained with uranyl citrate
and lead citrate, and examined (EM10, Zeiss, Eching,
Germany). The remaining kidney slices were then embed-
ded in plastic, containing hydroxymethylmethacrylate and
methylmethacrylate (GMA/MMA, Sigma-Aldrich Labor-
chemikalien GmbH, Seelze, Germany), as described previ-
ously (Hermanns et al. 1981). For qualitative and
quantitative morphological analyses, plastic sections with
a nominal section thickness of 1.5 lm were cut on a
Reichert-Jung 2050 rotary microtome (Leica, Wetzlar,
Germany) and stained with hematoxylin and eosin, peri-
odic acid Schiff (PAS), and periodic acid silver methena-
mine (PASM). For counting and sizing of glomeruli,
~140 consecutive sections with a nominal section thick-
ness of 1 lm were additionally cut from each GMA/
MMA block per case, using a Microm HM 360 rotary
microtome (Microm, Germany). From each section series,
every 20th section was systematically randomly selected
(6  2 kidney sections per case) and stained with PAS.
Quantitative stereological analyses
Design-based stereological methods, such as the physical
disector and point counting (Sterio 1984; Howard and
Reed 2004) were used for determination of the volumes of
distinct renal zones and nephron segments, of the total
number of glomeruli, the number and volume of proximal
tubular epithelial cells and of different glomerular cell
types, and of glomerular capillary volumes and lengths.
Plastic resin-embedded samples of kidney tissue were used
for quantitative stereological analyses, and stereological
estimates were corrected for embedding-related tissue
shrinkage.
Total volumes of the kidney, renal zones, and
distinct nephron segments
The kidney volume was obtained by dividing the kidney
weight by kidney density. The cross-sectional areas of the
kidney (Kid) and of individual renal zones in the kidney
(Kriz and Koepsell 1974; Kriz and Bankir 1988), that is,
the cortex, the outer stripe of the medulla (OSM), and
the inner stripe of the medulla together with the inner
zone of medulla (ISM/IZM) were planimetrically deter-
mined in micrographs of PASM-PAS-stained GMA/MMA
kidney sections (20  5 per case), using a VideoplanTM
image analysis system (Zeiss-Kontron, Eching, Germany).
The volume fractions of the cortex (VV(Cortex/Kid)), the
OSM (VV(OSM/Kid)), and the ISM/IZM (VV(ISM/IZM/Kid)) in
the kidney were calculated according to the principle of
Delesse (Howard and Reed 2004). The absolute volumes
of the individual renal zones (V(Cortex, Kid), V(OSM, Kid),
V(Cortex+OSM, Kid), V(ISM/IZM, Kid)) were calculated by mul-
tiplication of the volume fractions of the respective zones
in the kidney with the total kidney volume. The fractional
volumes of the glomeruli in the cortex (VV(Glom/Cortex)) of
distinct nephron segments within the cortex and OSM,
including proximal tubules (VV(PT/Cortex+OSM)) and other
tubules (VV(OT/Cortex+OSM)), and of the proximal tubular
epithelium (PTE) within the cortex and OSM (VV(PTE/Cor-
tex+OSM)) were determined by point counting (Weibel
1979) (370  89 points per case) in 11  2 systematically
randomly selected areas (Nyengaard 1999) of PASM-PAS-
stained GMA/MMA sections, as principally described
earlier (Hoeflich et al. 2002). The absolute volumes of
the respective nephron segments (V(PT, Cortex+OSM), V(PTE,
Cortex+OSM), V(Glom, Cortex)) were calculated from their cor-
responding volume fraction and the absolute volume of
the reference space (cortex, OSM).
Mean glomerular volume and total number of
glomeruli
The mean glomerular volume (v(Glom)) and the total
number of nephrons (glomeruli) in both kidneys (N(Glom,
Cortex)) were estimated, using the physical disector method
(Sterio 1984; Howard and Reed 2004), in combination
with systematic point counting, as principally described
in previous publications of our group (Hoeflich et al.
2002; Herbach et al. 2009). Per case, 6  2 PAS-stained
serial GMA/MMA sections pairs were systematically ran-
domly selected (nominal section thickness = 1 lm, disec-
tor height = 20 lm). Using an automated stereology
system (VIS-Visiopharm Integrator SystemTM Version
3.4.1.0 with newCASTTM software, Visiopharm A/S, Den-
mark), each 35  10 corresponding locations of the renal
cortex were then systematically randomly sampled at
40 9 final magnification in both sections, automatically
congruently aligned, and digitally superimposed with
unbiased counting frames (344,017 lm² area) and 9 9 9
point test grids. The cross-sectional area of cortical kidney
tissue present within each sampled counting frame
(A(Cortex)) was determined by point counting. In the sub-
sequent disector analyses, 62  12 Q (glomeruli) were
counted per case. The numerical volume density of glo-
meruli in the renal cortex was calculated as:
NV(Glom/Cortex) = (∑Q

(Glom)/h 9 ∑A(Cortex)) 9 fs³ with
fs = linear tissue shrinkage factor for GMA/MMA-
2016 | Vol. 4 | Iss. 5 | e12709
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embedded murine kidney tissue (0.91) (Herbach et al.
2011). N(Glom, Cortex) was then calculated as the product
of NV(Glom/Cortex) and V(Cortex, Kid). Subsequently, the
mean glomerular volume was estimated as v(Glom) = VV
(Glom/Cortex)/NV(Glom, Cortex).
To validate the precise disector heights used for the cal-
culation of the numerical volume densities of glomeruli
in the kidney, PTE cells in the renal cortex and glomeru-
lar cells in the glomeruli, the thicknesses of GMA/MMA
and Epon sections were controlled, using an orthogonal
resectioning technique, as described previously (Hoeflich
et al. 2002). From the GMA/MMA and Epon section ser-
ies, a section that was not sampled for the disector analy-
ses was randomly selected and re-embedded in Epon
resin, perpendicularly to its original section plane. The
thickness of the re-embedded sections was then measured
in image prints of subsequently prepared AzurII/Safranin-
stained semithin Epon sections taken at 1000 9 magnifi-
cation, using a semiautomatic image analysis system
(Videoplan, Zeiss-Kontron, Germany). Per case, four
measurements were made. Since the measured mean
thickness of re-embedded Epon sections was
0.501  0.005 lm and 1.037  0.035 lm for GMA/
MMA sections, a section thickness 0.5 lm, respectively of
1.0 lm was consistently used for calculation of the disec-
tor volumes.
Number and volumes of glomerular cells and of
PTE cells
The mean volume and total number of PTE cells, the
mean numbers of distinct glomerular cell types per
glomerulus (C: All glomerular cells; Pod: Podocytes, M-E:
Mesangial and endothelial cells), and the mean podocyte
volume were unbiasedly determined, applying the physical
disector method (Sterio 1984; Howard and Reed 2004),
principally as described above. For this, the numerical vol-
ume density of PTE cells in the cortex and of glomerular
cells in the glomerulus was unbiasedly estimated in con-
secutive serial semithin sections of Epon-embedded corti-
cal kidney tissue samples; per section series, 2–3 pairs of
sections with 1.5-lm distance between these sections, that
is, the nth and the n + 3rd section from a series cut with
a nominal section thickness of 0.5 lm, were systematically
randomly sampled (Howard and Reed 2004). Per case, the
corresponding profiles of 9  1 systematically randomly
sampled glomeruli were photographed at 400 9 magnifi-
cation in both sections of a section pair, using a Leica
DFC 320 camera (Leica, Germany) connected to a micro-
scope (Orthoplan, Leitz, Germany). Images including a
size ruler were printed and overlaid with a plastic trans-
parency with 576 equally spaced test points. The areas of
the glomerular cross-sections (A(Glom)) were planimetri-
cally measured, using a VideoplanTM image analysis sys-
tem (Zeiss-Kontron, Germany). The volume fraction of
podocytes in the glomeruli VV(Pod/Glom) was estimated
from the fraction of points hitting podocyte section pro-
files, and points hitting the corresponding reference space,
that is, the glomerular cross-section profile (Howard and
Reed 2004). On the average, 559  273 points were
counted per case. All glomerular cell nuclei profiles (C,
Pod, M-E) sampled within a glomerular cross-section in
the first (=reference) section, which were not present in
the corresponding glomerular section profile in the second
(=look-up) section, were counted (Q). The operation
was then repeated by interchanging the roles of the look-
up section and the reference section, increasing the effi-
ciency of cell nuclei counting by factor two. On the aver-
age, 228  48 glomerular cell (C) nuclei (Q) were
counted per case (Pod: 69  17; M-E: 160  41). The
numerical volume density of glomerular cells in the
glomerulus (NV(C/Glom), NV(Pod/Glom), NV(M-E/Glom)) was
then calculated from the number of Q counted per cell
type and the respective disector volume, defined by the
cumulative areas of analyzed glomerular section profiles
and the distance (disector height = 1.5 lm) between the
examined section pairs: NV(X/Glom) = (∑Q

(X)/
h 9 ∑A(Glom)) 9 fs³ with X = C, or Pod, or M-E; h = di-
sector height (1.5 lm) and fs = linear tissue shrinkage fac-
tor for Epon-embedded murine kidney tissue (0.95)
(Herbach et al. 2009). The mean number of cells per
glomerulus (N(C,Glom)) and of podocytes per glomerulus
(N(Pod,Glom)) was calculated by multiplying the numerical
volume density of the respective glomerular cells in the
glomerulus with the mean glomerular volume (refer to
section 2.6.2.2). The mean podocyte volume (v(Pod)) was
calculated dividing VV(Pod/Glom) by NV(Pod/Glom).
The mean volume (v(PTE cell, Cortex+OSM) and the total
number of PTE cells (N(PTE cells, Cortex+OSM)) were assessed
in an analogous manner. Digital microscopic images (taken
at 400 9 magnification) of systematically randomly
selected fields (11  3 per case) within the sampled disec-
tors were digitally superimposed with an unbiased count-
ing frame (Howard and Reed 2004) of known area
(12,543 lm2), and a grid of equally spaced test points (68
points per counting frame). The volume density of the PTE
in the renal cortex and the OSM (VV(PTE/Cortex+OSM)) was
estimated by point counting, as the fraction of points hit-
ting PTE cell section profiles, and points hitting the renal
cortical tissue section area. On the average, 727  331
points were counted per case. The numerical density of
PTE cells in the renal cortex (NV(PTE cells/Cortex+OSM)) was
calculated from averagely 66  17 PTE cells (Q) counted
within the unbiased counting frames of all investigated dis-
ectors per case, and the corresponding cumulative disector
volumes per case (product of the disector height (1.5 lm)
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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and the cumulative area of the cortical kidney tissue within
the counting frames in all examined disectors): NV(PTE cells/
Cortex+OSM) = (∑Q

(PTE cells)/h 9 ∑A(Cortex+OSM)) x fs³
with h = disector height (1.5 lm) and fs = linear tissue
shrinkage factor for Epon-embedded murine kidney tissue
(0.95) (Herbach et al. 2009). N(PTE cells, Cortex+OSM) was
calculated as the product of NV(PTE cells/Cortex+OSM) and
V(Cortex+OSM, Kid). The mean volume of PTE cells (v(PTE cell,
Cortex+OSM)) was obtained by dividing VV(PTE cells/Cor-
tex+OSM) by NV(PTE cells/Cortex+OSM).
Mesangial and glomerular capillary volumes
The volume densities of capillaries, and of the mesangium
within the glomeruli (VV(Cap/Glom) and VV(Mes/Glom)) were
determined by point counting (fraction of points hitting
capillary section profiles, or the mesangial area in PAS-
stained sections, respectively, and points hitting the
glomerular section profile) in 36  5 systematically ran-
domly sampled glomerular profiles in PAS-stained GMA/
MMA sections at 200 9 magnification. Per case,
420  58 points were counted. The mean mesangial and
capillary volumes per glomerulus (v(Mes, Glom) and v(Cap,
Glom)) were calculated as the product of the respective
numerical volume density in the glomerulus and the
mean glomerular volume (v(Glom)). The total volume of
glomerular capillaries in the kidneys was calculated as
V(Glom-cap, Kid) = VV(Cap/Glom) 9 V(Glom, Cortex).
Mean length of the capillaries in a glomerulus
The mean length of the capillaries in a glomerulus (L(Cap,
Glom)) was determined in the same glomerular profiles
sampled in the serial semithin Epon sections used for esti-
mation of glomerular cell numbers. The number of
glomerular capillary section profiles (ΣQ(Cap) =
671  155 per case) present within the examined
glomerular section profiles was counted. The cumulative
glomerular tuft profile area of all examined glomerular
section profiles (ΣA(Glom)) was measured planimetrically,
as described above. The length density of capillaries per
glomerulus was calculated as LV(Cap/Glom) = 2 9 QA(Cap/
Glom) 9 fs
2, with QA(Cap/Glom) = ΣQ(Cap)/ΣA(Glom) and
fs = 0.95. L(Cap, Glom) was then obtained as: L(Cap,
Glom) = Lv(Cap/Glom) 9 v(Glom) (Nyengaard 1999;
Howard and Reed 2004). The total length of glomerular
capillaries in the kidneys (L(Glom-cap, Kid)) was calculated
as: L(Glom-cap, Kid) = L(Cap, Glom) 9 N(Glom, Kid).
Glomerular basement membrane (GBM) thickness
and filtration slit frequency (FSF)
The thickness of the GBM was determined by the orthog-
onal intercept method as described earlier (Ramage et al.
2002; El-Aouni et al. 2006; Herbach et al. 2009). Per case,
ultrathin sections of six glomeruli, that were sampled
from semithin sections, were prepared for TEM, and
peripheral glomerular capillary loops were photographed
(7  1 pictures per case) in a predetermined manner (by
half turns of the stage handle). Photographs were devel-
oped to a final print magnification of 54,324 9 , and
covered by a transparent 2.5-cm2 grid. Where gridlines
transected the GBM, the shortest distance between the
endothelial cell membrane and the outer lining of the
lamina rara externa underneath the cell membrane of the
epithelial foot processes was measured, using a logarith-
mic ruler template with dimensions and midpoints, as
described in detail earlier (Ramage et al. 2002). The true
harmonic mean thickness (Th(GBM)) of the GBM was esti-
mated as: Th(GBM) = (8/3p) 9 (10
6/M) 9 lh(GBM), with lh
(GBM) (apparent harmonic mean GBM thickness) = ∑
Number of observations/∑ (Midpoints 9 number of
observations), and M = final print magnification. On the
average, 46  7 (range: 31–66) intercepts per animal were
measured. The FSF was determined in the same electron
micrographs, by counting the number of epithelial filtra-














Body weight (BW) (g) m 15.28  1.49† 21.50  0.87† 33.10  0.83†* 51.47  1.81†* 37.60  1.15† 71.86  4.86†*
f 10.98  1.70† 18.20  2.43† 26.16  1.42†* 47.47  2.75†* 34.82  3.87† 55.79  6.34†*
Kidney weight (KW) (mg) m 274  52 329  66 718  83* 785  133* 612  140†* 1182  255†*
f 160  18 246  14 351  49†* 564  112†* 433  46†* 771  176†*
Relative KW (% of BW) m 1.8  0.4 1.5  0.3 2.2  0.3†* 1.5  0.2† 1.6  0.4* 1.7  0.4
f 1.5  0.1 1.4  0.3 1.3  0.2* 1.2  0.2 1.2  0.1* 1.4  0.2
Numbers of examined animals (75 days old) are given in brackets. Data are means  SD. One-way ANOVA with LSD post hoc test.
*Statistically significant differences (P ≤ 0.05) between male and female mice of the identical genotype.
†Statistically significant differences (P ≤ 0.05) between sex-matched I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice.
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tion slits divided by the length of the peripheral capillary
wall at the epithelial interface, as described earlier (El-
Aouni et al. 2006). On the average, 162  50 (range: 71–
291) filtration slits were counted per animal.
Statistical analyses
All data are presented as means  SD. Data were ana-
lyzed by one-way ANOVA with LSD post hoc tests (IBM
SPSS Statistics, Version 18), taking the effects of sex and
genotype into account. P ≤ 0.05 were considered signifi-
cant. To depict effects of GH-transgene expression on I/
, I+/, and I+/+ mice, sex-matched GH-transgenic versus
non-GH-transgenic mice with corresponding Igf1 geno-
types were compared: I/ versus I//G, I+/ versus I+/
/G, and I+/+ versus G, if not stated otherwise. Gender-
specific differences were analyzed by comparison of male
versus female mice of identical genotypes.
Results
Body weight, kidney weight, and kidney
volume
IGF1-deficient mice (I//G and I/ mice) displayed
approximately 60% lower body and kidney weights and
kidney volumes, as compared to mice with intact or
heterozygously disrupted igf1 alleles (Tables 1 and 2).
GH-transgenic mice consistently displayed significantly
higher body weights than non-GH-transgenic mice with
identical Igf1 status (G vs. I+/+; I+//G vs. I+/; and I/
/G vs. I/; Table 1). Similarly, I//G, I+//G, and G
mice exhibited higher kidney weights and kidney vol-
umes than I/, I+/, and I+/+ mice, respectively. How-
ever, the differences of kidney weights and volumes did
not reach statistical significance in male I+//G versus
I+/, and in female I//G versus I/ mice (Tables 1
and 2). Except for male I+//G versus I+/ mice, the
relative kidney weights (% of body weight) did not dif-
fer significantly between GH-transgenic and non-GH-
transgenic mice of corresponding igf1 allele status
(Table 1).
Histological and ultrastructural findings
I/ mice displayed remarkably smaller glomerular profiles
than mice of all other genotypes. In contrast, the glomeru-
lar profiles of GH-transgenic mice (I//G, I+//G and G
mice) consistently appeared greatly enlarged, as compared
to non-GH-transgenic mice with the same Igf1 status (I/,
I+/, and I+/+ mice) (Fig. 1). Histopathological examina-
tion revealed glomerulosclerotic lesions present in all GH-
transgenic genotypes (I//G, I+//G, and G mice), com-
prising glomerular mesangial expansion, matrix accumula-
tion and hypercellularity, multifocal capillary hyalinosis,
capillary collapse, formation of synechiae between the
glomerular tuft and the capsule of Bowman, crescent for-
mation (Figs. 1 and 2), as well as tubulo-interstitial lesions,
such as mild inflammatory cell infiltration, interstitial
fibrosis, and multifocal tubular atrophy, along with signs of














VKid (mm³) m 261  49 313  63 683  79* 748  127* 583  133†* 1125  243†*
f 153  17 235  14 334  46†* 537  107†* 413  44†* 734  167†*
VV(Cortex/Kid) m 0.65  0.02* 0.63  0.01 0.64  0.02†* 0.61  0.01† 0.61  0.03 0.62  0.03*
f 0.62  0.01* 0.65  0.01 0.60  0.02* 0.62  0.03 0.60  0.02† 0.65  0.02†*
V(Cortex, Kid) (mm³) m 170  31 198  41 438  49* 455  84* 355  98†* 691  123†*
f 94  9 153  10 199  30†* 332  54†* 246  23†* 480  115†*
VV(OSM/Kid) m 0.22  0.01 0.21  0.01 0.23  0.01 0.25  0.01 0.23  0.02* 0.24  0.02
f 0.22  0.02 0.21  0.01 0.23  0.04 0.24  0.01 0.25  0.02†* 0.22  <0.00†
V(OSM, Kid) (mm³) m 57  11 66  16 157  21* 188  29* 134  32† 273  82†*
f 34  7 50  5 77  15†* 130  29†* 105  17† 160  35†*
VV(ISM&IZ/Kid) m 0.13  <0.00 0.16  0.01 0.13  0.02* 0.14  0.01 0.16  0.04 0.14  0.03
f 0.16  0.01 0.14  0.03 0.17  0.02†* 0.14  0.02† 0.15  0.01 0.13  0.02
V(ISM&IZ, Kid) (mm³) m 34  6 48  7 89  20* 105  15* 93  15 162  50
f 24  1 32  6 58  10* 76  25* 61  7 95  22
Numbers of examined animals are given in brackets. Data are means  SD. One-way ANOVA with LSD post hoc test.
*Statistically significant differences (P ≤ 0.05) between male and female mice of the identical genotype.
†Statistically significant differences (P ≤ 0.05) between sex-matched I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice.
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proteinuria, that is, accumulation of protein droplets in
proximal tubular epithelial cells, and tubular protein casts.
These alterations were most marked in G mice, followed by
I+//G, and I//G mice. In contrast, mice of non-GH-
transgenic genotypes (I/, I+/, and I+/+) did not show
glomerulosclerotic alterations. Ultrastructurally, the
glomerular podocytes of mice of GH-transgenic genotypes
(I//G, I+//G, and G) appeared enlarged, as compared to
non-GH-transgenic mice and displayed podocyte foot pro-
cess effacement (Fig. 3).
Urine analyses
Mice of all GH-transgenic genotypes (I//G, I+//G,
and G) demonstrated albuminuria from approximately
the fifth week of age onward. The areas and staining
intensities of albumin bands (~64 kDa) in SDS-PAGE-
based urine protein analyses were markedly increased in
G mice, as compared to I//G mice. Typically for
male GH-overexpressing mice (Norstedt and Palmiter
1984), male GH-transgenic mice of all examined Igf1
Figure 1. Kidney histology. I//G, I+//G, and G mice display glomerulosclerosis and larger glomerular section profile areas (glomerular
hypertrophy), as compared to I/, I+/, and I+/+ mice. Male mice at 11 weeks of age. Silver-PAS staining, GMA/MMA sections. Bars = 50 lm.
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genotypes (I//G, I+//G, and G) consistently displayed
drastically reduced major urinary protein (MUP) bands
(<20 kDa), as compared to male non-GH-transgenic
mice (Fig. 4).
Quantitative morphological findings
Volumes of distinct renal zones and nephron
segments
In GH-transgenic mice versus non-GH-transgenic mice
of the identical Igf1 status (G vs. I+/+, I+//G vs. I+/,
and I//G vs. I/), the volume fractions of the cortex
(VV(Cortex/Kid)), of the outer stripe of the medulla (VV
(OSM/Kid)), and of the inner stripe of the medulla
together with the inner zone of medulla (VV(ISM/IZM/
Kid)) in the kidneys showed only minor, slightly varying
(3–8%) differences (Table 2). The absolute volumes of
the cortex (V(Cortex, Kid)) and of the outer stripe of the
medulla (V(OSM, Kid)), however, were significantly
increased in G versus I+/+ mice, and in female I+//G
versus I+/ mice, but not in I//G versus I/ mice
(Table 2). Similarly, the total volumes of proximal
tubules, and of other tubules in the renal cortex and
the OSM (V(PT, Cortex+OSM) and V(OT, Cortex+OSM)) were
significantly increased in G versus I+/+, and female I+//
G versus I+/ mice as well, but not in I//G versus
I/ mice (Table 5). In contrast, the total volumes of
the glomeruli in the kidneys (V(Glom, Cortex)) were sig-
nificantly increased in all GH-transgenic mice versus
non-GH-transgenic mice of the identical Igf1 status
(Table 3).
Figure 2. Glomerular histology. I//G, I+//G, and G mice display glomerulosclerosis with glomerular mesangial expansion and matrix
accumulation, capillary hyalinosis, and crescent formation. Note the larger glomerular section profile areas in I//G, I+//G, and G mice, as
compared to I/, I+/, and I+/+ mice (glomerular hypertrophy). Female mice at 11 weeks of age. Silver-PAS staining, GMA/MMA sections.
Bars = 50 lm.
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Total number of glomeruli and mean glomerular
volume
GH-transgenic mice displayed significantly lower numeri-
cal volume densities of glomeruli in the renal cortex (NV
(Glom/Cortex)) than non-GH-transgenic mice of identical
Igf1 status, except for I+//G versus I+/ male mice. The
total numbers of glomeruli in the kidneys (N(Glom, Cor-
tex)), however, did not differ significantly between I
//G
versus I/, I+//G versus I+/, and G versus I+/+ mice
(Table 3). However, corresponding to their significantly
smaller kidney and cortex volumes (Table 2), the total
numbers of glomeruli in IGF1-deficient (I//G and I/
) mice were approximately 25% lower than in mice
with intact (I+/+ and G mice), or heterozygously
disrupted igf1 alleles (I+/ and I+//G mice). The mean
glomerular volume v(Glom), as well as the mean glomeru-
lar volume related to body weight (v(Glom)/BW) was sig-
nificantly increased in mice of all GH-overexpressing
genotypes, as compared to non-GH-transgenic mice of
identical Igf1 status (Table 3, Fig. 5). On the average, I//
G, I+//G, and G mice displayed a 2.7-fold higher mean
glomerular volume, as compared to I/, I+/, and I+/+
mice. Except for female G versus I+/+ mice, also the mean
glomerular volume related to kidney weight (v(Glom)/KW)
was significantly increased in GH-transgenic mice, as com-
pared to non-GH-transgenic mice of identical Igf1 status
(Table 3).
Mean mesangial and capillary volumes and mean
capillary lengths per glomerulus and total
glomerular capillary lengths and volumes in the
kidneys
Mice of all GH-transgenic genotypes (I//G, I+//G,
and G) consistently displayed significantly higher volume
densities of the mesangium in the glomeruli (VV(Mes/
Glom)), as well as significantly higher mean mesangium
volumes per glomerulus (v(Mes, Glom)), as compared to
non-GH-transgenic mice of identical Igf1 status (I/,
Figure 3. Transmission electron microscopy of peripheral glomerular capillary walls. Mice of GH-transgenic genotypes (I//G, I+//G, and G)
consistently exhibit podocyte foot process effacement and reduced filtration slit frequency, as compared to mice of non-GH-transgenic
genotypes (I/, I+/, and I+/+). Male mice at 11 weeks of age. Bars = 500 nm.
Figure 4. SDS-PAGE urine protein analysis. Representative gel of
11-week-old male mice. Spot urine samples were diluted to
identical creatinine concentrations (3 mg/dL) and run on a 12%
SDS-PAGE. Coomassie staining. The I//G and G mice display
albuminuria (bands at approx. 63 kDa, arrow). Also note the
drastically reduced intensity of the major urinary protein (MUP)
bands at approximately 18 kDa in urine samples of male I//G and
G mice, as compared to male I/ and I+/+ mice.
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I+/ and I+/+, respectively). The capillary volume per
glomerulus (V(Cap, Glom)), the total volume of the
glomerular capillaries in the kidneys (V(Glom-cap, Kid)),
the length density of capillaries in the glomeruli (LV(Cap/
Glom)), the mean length of the capillaries per glomerulus
(L(Cap, Glom)), and the total length of the glomerular
capillaries in the kidneys (L(Glom-cap, Kid)) were also sig-
nificantly increased in I//G versus I/, I+//G versus
I+/, and G versus I+/+ mice (Table 4).
Number of cells per glomerulus and mean
podocyte volumes
Due to a significant increase of the numbers of endothelial
and mesangial cells per glomerulus, the mean total num-
bers of cells per glomerulus in I//G, I+//G, and G mice
were significantly increased, as compared to I/, I+/, and
I+/+ mice, respectively. In contrast, the mean numbers of
podocytes per glomerulus were not significantly different
between I//G and I/, I+//G and I+/, or G and I+/+
mice (Fig. 6). However, the mean podocyte volume was
significantly increased in GH-transgenic mice, as compared
to non-GH-transgenic mice of the identical Igf1 status,
except for male I+//G versus I+/ mice (Fig. 7A).
Filtration slit frequency and glomerular basement
membrane thickness
Compared to GH-transgenic (I//G, I+//G and G) mice,
non-GH-transgenic mice (I/, I+/, and I+/+) exhibited
significantly higher glomerular filtration slit frequencies
(FSF) (Fig. 7B), whereas the true harmonic mean thick-
ness of the glomerular basement membrane (GBM) was
not significantly different in I//G versus I/, I+//G
versus I+/, and G versus I+/+ mice (Table 4).
Volume densities and total volumes of proximal
tubular epithelial cells in the cortex and the OSM,
and total numbers and mean volumes of PTE cells
The volume densities of proximal tubular epithelial (PTE)
cells in the renal cortex and the OSM (VV(PTE/Cortex+OSM))
did not differ significantly between I//G and I/, I+//
















VV(Glom/Cortex) m 0.021  0.006† 0.049  0.002† 0.020  0.002†* 0.051  0.016† 0.025  0.003† 0.043  0.003†
f 0.024  0.005† 0.053  0.008† 0.031  0.004†* 0.050  0.005† 0.033  0.002 0.041  0.004
V(Glom, Cortex)
(mm³)
m 3.5  0.5† 9.7  1.8† 8.3  1.5† 22.5  3.9†* 7.8  0.8† 30.0  4.0†*
f 2.3  0.6† 8.2  1.5† 6.8  1.1† 16.3  1.5†* 8.1  0.3† 20.9  5.7†*
v(Glom)/BW
(lm³ 9 103/g)
m 9.1  1.6† 18.8  0.9† 7.5  1.3† 13.2  1.0† 6.4  1.2† 12.5  1.9†
f 9.6  1.5† 19.8  5.8† 8.0  1.6† 11.7  1.2† 6.9  0.6† 10.8  2.2†
v(Glom)/KW
(lm³/mg)
m 542  246† 1253  154† 355  52† 885  185† 442  84† 759  157†
f 665  163† 1451  382† 565  72† 1041  212† 565  74 768  143
NV(Glom/Cortex)
(n/mm³)
m 154  27†* 121  13†* 80  4* 76  20 104  7† 47  5†
f 231  26†* 158  44†* 146  11†* 91  15† 132  24† 66  7†
N(Glom, Cortex) m 25,967  5502 23,694  2652 33,648  2786 33,337  3677 32,342  2366 33,138  4375
f 21,794  3599 24,230  7391 31,871  2973 28,769  3015 32,716  4213 33,555  7815
Numbers of examined animals are given in brackets. Data are means  SD. One-way ANOVA with LSD post hoc test.
*Statistically significant differences (P ≤ 0.05) between male and female mice of the identical genotype.
†Statistically significant differences (P ≤ 0.05) between sex-matched I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice.
Figure 5. Mean glomerular volume at 11 weeks of age. I//G, I+//
G, and G mice display significantly higher mean glomerular volumes,
as compared to I/, I+/, and I+/+ mice. Data are means  SD. One-
way ANOVA with LSD post hoc test. Statistically significant
differences (P ≤ 0.05) are indicated by different superscripts. The
numbers of examined animals are given in brackets.
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G and I+/, or G and I+/+ mice (Table 5). The total vol-
ume of PTE cells in the cortex and the OSM (V(PTE, Cor-
tex+OSM)) were significantly increased in G versus I
+/+
mice. In I//G versus I/, and in I+//G versus I+/
mice the V(PTE, Cortex+OSM) was increased, but the differ-
ences did not reach statistical relevance (Table 5). The
total numbers of PTE cells in the kidneys (N(PTE cells, Cor-
tex+OSM)) were significantly increased in G versus I
+/+ and
in I+//G versus I+/ mice, but not in I//G versus I/
mice, whereas the mean volume of PTE cells (v(PTE cells,
Cortex+OSM)) was virtually unaltered between GH-trans-
genic and non-GH-transgenic mice of corresponding Igf1
status (Fig. 8).
Discussion
Although the formal pathogenesis of progressive
glomerulosclerosis in GH-transgenic mice has been well
characterized, the exact mechanisms inducing stimulation
of renal and glomerular growth, glomerular and podocyte
hypertrophy, mesangial and endothelial hyperplasia, and
the well-known subsequent renal lesion patterns seen in
GH-transgenic mice are yet not fully understood. Several
of the various biological actions of GH, such as stimula-
tion of somatic growth, are indirectly mediated by GH-
induced IGF1 (Le Roith et al. 2001). Although GH stimu-
lates the release of predominantly liver-derived IGF1 into
the circulation, elevated systemic IGF1 levels are not
essential for mediation of GH-induced IGF1-dependent
growth-promoting actions (Yakar et al. 1999; Le Roith
et al. 2001), since several, if not the majority, of the
growth-stimulating effects of IGF1 are actually mediated
by locally produced IGF1, acting in an autocrine or para-
crine fashion (Le Roith et al. 2001; Stratikopoulos et al.
2008). The exact roles of excess GH and of IGF1 in stim-
ulation of renal and glomerular growth in GH-transgenic














VV(Mes/Glom) m 0.10  0.03† 0.25  0.05† 0.11  0.03† 0.23  0.07† 0.11  0.03† 0.25  0.06†
f 0.09  0.02† 0.21  0.07† 0.12  0.03† 0.21  0.04† 0.09  0.01† 0.23  0.05†
v(Mes/Glom) (910³ lm³) m 15  9† 99  15† 25  8† 155  54† 25  6† 227  64†*
f 9  4† 75  23† 25  5† 120  24† 24  5† 143  37†*
VV(Cap/Glom) m 0.63  0.03† 0.51  0.05† 0.64  0.02†* 0.44  0.03† 0.59  0.07† 0.46  0.04†*
f 0.58  0.04† 0.44  0.07† 0.58  0.03* 0.53  0.03 0.58  0.05 0.56  0.06*
V(Cap, Glom) (910³ lm³) m 88  22† 209  36† 153  33† 296  10† 144  30† 418  38†*
f 62  19† 157  48† 125  26† 297  50† 147  28† 346  59†*
V(Glom-cap, Kid) (mm³) m 2.1  0.2† 5.0  1.4† 5.0  1.0† 9.9  1.3† 4.5  0.8† 14.1  1.4†
f 1.3  0.3† 3.5  0.3† 4.4  1.1† 8.6  1.1† 4.7  0.4† 11.5  2.7†
LV(Cap/Glom) (m/mm³) m 11.93  0.26† 7.10  1.19† 12.41  1.61† 7.35  1.30† 11.83  1.28† 5.98  0.47†*
f 12.30  0.40† 8.36  1.54† 11.86  0.61† 7.90  0.86† 11.12  1.02† 8.94  1.97†*
L(Cap, Glom) (mm) m 1.67  0.46† 2.87  0.50† 2.93  0.28† 4.91  0.78† 2.87  0.57† 5.43  0.54†
f 1.31  0.37† 2.98  1.02† 2.53  0.24† 4.41  0.19† 2.81  0.57† 5.59  1.66†
L(Glom-cap, Kid) (m) m 38.7  4.4† 68.1  16.1† 95.6  13.7† 162.6  25.9†* 92.1  12.8† 180.6  35.0†
f 28.4  7.2† 66.9  6.5† 80.6  9.8† 126.9  16.4†* 90.1  9.7† 181.5  49.3†
Th(GBM) (nm) m (n = 3) 157  5 160  7 152  7 155  6 164  6 164  5
f (n = 3) 155  5 165  10 153  6 156  6 165  18 158  10
Nv(Cells/Glom) (n/10
5 lm³) m 131  46† 91  20† 116  11† 69  9† 120  22† 62  4†
f 186  24† 110  19† 124  11† 65  5† 107  11† 72  8†
Nv(Ec&Mc/Glom) (n/10
5 lm³) m 83  29* 67  14 78  8† 51  6† 80  17† 49  3†
f 116  14†* 80  10† 80  10† 47  4† 67  6 56  5
Nv(Pod/Glom) (n/10
5 lm³) m 49  18†* 24  6† 38  4† 18  3† 40  6† 14  2†
f 69  10†* 30  11† 43  2† 17  1† 40  4† 17  4†
Vv(Pod/Glom) m 0.12  0.04* 0.12  0.02 0.13  0.02† 0.09  0.01† 0.14  0.01 0.15  0.02
f 0.16  0.05* 0.14  0.01 0.14  0.02 0.11  0.01 0.13  0.01 0.12  0.03
V(Pod, Glom) (10³ lm³) m 18  5† 49  5† 34  6† 58  7† 33  8† 132  19†*
f 17  4† 50  15† 29  6† 62  13† 31  3† 75  17†*
Numbers of examined animals are given in brackets. Data are means  SD. One-way ANOVA with LSD post hoc test.
*Statistically significant differences (P ≤ 0.05) between male and female mice of the identical genotype.
†Statistically significant differences (P ≤ 0.05) between sex-matched I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice.
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mice, however, are still unclear. Since different glomerular
cell types simultaneously express both GH and IGF1
receptors (Doi et al. 2000; Tack et al. 2002; Karl et al.
2005; Reddy et al. 2007; Vasylyeva and Ferry 2007;
Bridgewater et al. 2008), a clear differentiation of excess
GH and IGF1 actions promoting glomerular hypertrophy
and glomerulosclerosis in vivo is complicated. Almost
25 years ago, it was demonstrated that both GH-trans-
genic and Igf1-transgenic mice do develop glomerular
hypertrophy. However, the magnitude of glomerular
enlargement displayed by Igf1-transgenic mice is much
lower than the glomerular hypertrophy exhibited by GH-
transgenic mice, and in contrast to GH-transgenic mice,
Igf1-transgenic mice do not develop glomerulosclerosis
(Doi et al. 1988, 1990). These observations indicate that
both excess GH-dependent and GH-independent elevation
of systemic IGF1 levels stimulate glomerular growth.
However, stimulation of glomerular growth by systemi-
cally elevated IGF1 levels in Igf1-transgenic mice without
concurrently elevated systemic GH levels is obviously not
sufficient to trigger the development of glomerulosclerosis
(Doi et al. 1990). These findings of course do not eluci-
date the potential role of excess GH-stimulated, locally
produced glomerular IGF1 for the development of
glomerular hypertrophy and glomerulosclerosis in GH-
transgenic mice with systemically elevated GH levels.
To dissociate the relative contributions of IGF1-
mediated and IGF1-independent effects of GH excess on
Figure 6. Number of cells per glomerulus of 11-week-old mice. The total glomerular cell numbers, as well as the numbers of mesangial and
endothelial glomerular cells per glomerulus are significantly higher in I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice. In contrast,
the number of podocytes per glomerulus does not significantly differ between GH-transgenic mice and non-GH-transgenic mice with identical
Igf1 status. Data are means  SD. One-way ANOVA with LSD post hoc test. Statistically significant differences (P ≤ 0.05) are indicated by
different superscripts. The numbers of examined animals are given in brackets.
Figure 7. Mean podocyte volume (A) and filtration slit frequency (B) at 11 weeks of age. I//G, I+//G, and G mice display significantly higher
mean podocyte volumes, as compared to I/, I+/, and I+/+ mice. The number of podocyte–foot process filtration slits per mm of the
glomerular basement membrane (GBM) is significantly reduced in I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice. Data are
means  SD. One-way ANOVA with LSD post hoc test. Statistically significant differences (P ≤ 0.05) are indicated by different superscripts. The
numbers of examined animals are given in brackets.
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stimulation of renal growth and subsequent development
of progressive glomerulosclerosis in vivo, the present
study applied model-independent stereological methods
on kidney samples of a unique collective of GH-trans-
genic IGF1-deficient mice. Since permanently excessively
elevated levels of GH in G mice induce a simultaneous
increase in endogenous IGF1 levels, none of the pheno-
typical effects observed in G mice can clearly be attributed
to GH or IGF1 alone by comparing G mice to I+/+ mice.
For the same reason, a comparison of G mice and I//G
mice is also not suitable to identify IGF1-independent
effects of excess GH on renal growth and pathology.
Additionally, IGF1 is a crucially important factor for
embryonal and fetal renal growth and nephronogenesis,
and therefore the initial “kidney status” (characterized by,
e.g., kidney volume, nephron number, initial mean
glomerular or podocyte volume) is not comparable
between Igf1-knockout mice and mice with intact igf1
alleles. Therefore, a meaningful dissociation of IGF1-inde-
pendent effects of excess GH from GH-induced IGF1-
mediated effects can only be performed by comparing I/
/G mice and I/ mice. Correspondingly, groups of
Table 5. Quantitative stereology of renal tubules.
Parameter n (m/f)
I/ I//G I+/ I+//G I+/+ G
5/3 3/4 5/5 5/5 5/5 5/5
VV(PT/Cortex+OSM) m 0.77  0.03 0.74  0.04 0.77  0.02 0.74  0.01 0.72  0.02† 0.77  0.02†
f 0.78  0.02† 0.73  0.02† 0.78  0.04† 0.72  0.02† 0.74  0.01 0.75  0.02
V(PT, Kid) (mm³) m 175  37 196  44 456  47* 478  84* 352  96† 741  162†*
f 101  11 148  8 217  41†* 333  63†* 261  29† 479  117†*
VV(OT/Cortex+OSM) m 0.15  0.02 0.16  0.02 0.16  0.01* 0.15  0.01* 0.19  0.01†* 0.14  0.01†
f 0.14  0.01 0.16  0.01 0.14  0.03†* 0.17  0.01†* 0.17  0.01* 0.16  0.01
V(OT, Cortex+OSM) (mm³) m 34  5 41  9 96  16* 97  18 93  20†* 137  30†*
f 18  4 33  3 38  3†* 79  15† 59  8†* 100  23†*
4/3 3/4 4/4 4/4 4/4 4/4
VV(PTE/Cortex+OSM) m 0.29  0.01 0.30  0.05 0.32  0.02 0.35  0.06 0.33  0.04 0.30  0.05
f 0.31  0.04 0.29  0.02 0.36  0.03 0.30  0.05 0.32  0.01 0.29  0.04
V(PTE, Kid) (mm³) m 68  11 78  6 182  14* 216  18* 154  21† 304  88†*
f 40  8 59  5 95  7* 134  40* 111  19† 199  56†*
NV(PTE cells/Cortex+OSM)
(n 9 10³/mm³)
m 79  16* 90  25 65  15* 76  13 65  13 51  4
f 109  7* 110  17 88  21* 77  14 69  4 59  8
Numbers of examined animals are given in brackets. Data are means  SD. One-way ANOVA with LSD post hoc test.
*Statistically significant differences (P ≤ 0.05) between male and female mice of the identical genotype.
†Statistically significant differences (P ≤ 0.05) between sex-matched I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice.
Figure 8. Total numbers (A) and mean volumes (B) of proximal tubular epithelial cells at 11 weeks of age. The total number of PTE cells is
significantly increased in I+/+ versus G mice and in I+//G versus I+/ mice, but not in I//G versus I/ mice. The mean volume of PTE cells is
not significantly different in I/ versus I//G, I+/ versus I+//G, and I+/+ versus G mice. Data are means  SD. One-way ANOVA with LSD post
hoc test. Statistically significant differences (P ≤ 0.05) are indicated by different superscripts. The numbers of examined animals are given in
brackets.
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mice with identical IGF1 genotypes were compared
throughout the present study (I/ vs. I//G, I+/ vs. I+/
/G, and I+/+ vs. G).
Implementation of studies on Igf1-knockout mice is
generally hindered by the low perinatal survival rates of
IGF1-deficient mice, restricting the numbers of animals
available for investigation (Liu et al. 1993; Liu and LeR-
oith 1999; Lupu et al. 2001; Blutke et al. 2014). Although
the numbers of examined I/ and I//G mice were lim-
ited to 7–8 mice per genotype, the results of exhaustive
quantitative stereological analyses were capable to clearly
identify common and dissociated growth-promoting
effects of GH and IGF1 on the kidney, distinct kidney
structures, and cell types.
Confirming the essential role of IGF1-mediated GH-sti-
mulated postnatal somatic growth (Powell-Braxton et al.
1993; Liu and LeRoith 1999; Le Roith et al. 2001; Blutke
et al. 2014), I/ and I//G mice reached only ~35%
and ~57% of the body weight of sex-matched WT control
animals at 75 days of age, although the body weights of
I//G mice were significantly higher than those of I/
mice (Blutke et al. 2014).
In the kidneys, a disproportional stimulation of renal
growth by GH-overexpression, as indicated by increased
relative kidney weights in elder (>120 days) mice of vari-
ous GH-transgenic mouse lines (Brem et al. 1989; Wanke
et al. 1991), was yet not present in 75 days old GH-trans-
genic mice versus non-GH-transgenic mice of the same
igf1 allele status. Interestingly, the effect of GH overex-
pression on the absolute volumes of the kidneys and of
distinct kidney compartments, including the cortex, the
outer stripe of the medulla (OSM), and the proximal
tubules, differed in GH-transgenic Igf1-knockout mice, as
compared to GH-transgenic mice with intact igf1 alleles.
On the average, the total kidney weights and volumes of
G mice were significantly increased by 86%, as compared
to sex-matched I+/+ mice (93% in male mice and 78% in
female mice). In contrast, the nonsignificant increase of
kidney weights and volumes in I//G versus I/ mice
accounted merely for 37% (20% in male mice and 54%
in female mice), supporting the finding that stimulation
of overall renal growth by GH excess is largely but not
exclusively mediated by IGF1 (Doi et al. 1990). The
marked increase of the kidney volume in G versus I+/+
mice was caused by a significant, on the average 95%
increase in the volume of the renal cortex (V(Cortex, Kid)),
and by a significant, on the average 78% increase in the
OSM (V(OSM, kid)) in male and female G versus I
+/+ mice.
The increased volumes of the renal cortex and the OSM
mainly resulted from a significant, on the average 97%
enlargement of the volume of proximal tubules (V(PT, Cor-
tex & OSM)). The latter was found due to a significant
increase in the total volume of the proximal tubular
epithelia (PTE) in the renal cortex and the OSM. Quanti-
tative stereological analyses revealed a hyperplastic growth
of PTE cells to account for the increased total PTE vol-
ume in G versus I+/+ mice. Although the mean cellular
volume of PTE cells was virtually unaltered in all GH-
overexpressing versus non-GH-transgenic mice of identi-
cal Igf1 status, the total number of PTE cells in G versus
I+/+ mice was significantly increased by 76%. In contrast,
the volumes of the renal cortex, the OSM, the proximal
tubules, the PTE, and the total PTE cell numbers in I//
G versus I/ mice and in I+//G versus I+/ mice were
throughout increased by just ~30–40%. However, due to
the limited number of Igf1-knockout mice of 75 days of
age available for analysis, these differences did not (yet)
reach the level of statistical significance. The observed dif-
ferences in stimulation of tubular growth between G, I+/
/G, and I//G mice show that IGF1 is a major media-
tor of PTE hyperplasia induced by GH excess, consistent
with previously reported proliferative/mitogenic effects of
IGF1 on proximal tubular epithelial cells in vitro (Blazer-
Yost et al. 1992).
In addition to their dwarf phenotype, and their propor-
tionally reduced kidney sizes, the complete deficiency of
IGF1 also essentially affected renal development in I/
and I//G mice. The numbers of nephrons (N(Glom,Kid))
in the small kidneys of I/ and I//G mice were con-
siderably lower than in mice with intact or heterozygously
deleted igf1 alleles, while Igf1-haploinsufficiency in I+/
and I+//G mice did not detectably affect nephron num-
bers, as compared to G or I+/+ mice. Furthermore, GH
overexpression did also not significantly influence the
number of nephrons in I//G versus I/, I+//G versus
I+/, and G versus I+/+ mice, indicating that GH overex-
pression does not affect nephronogenesis in GH trans-
genic mice.
In GH transgenic mice, progressive glomerular and
podocyte hypertrophy, subsequent podocyte damage, and
albuminuria are pathogenetic key lesions in the develop-
ment of glomerulosclerosis (Wanke et al. 2001; Paven-
stadt et al. 2003; Wiggins 2007). The mean glomerular
volume and the mean podocyte volume, as the relevant
parameters for assessment of glomerular and podocyte
hypertrophy, were significantly increased in all GH-trans-
genic mice versus their non-GH-transgenic controls of
identical Igf1 status. In parallel, mice of all investigated
GH-transgenic genotypes displayed glomerulosclerotic
kidney lesions, significantly reduced podocyte filtration
slit frequencies, and albuminuria. The glomerulosclerosis
indices of the mice examined in the present study have
already been reported in a previous publication (Blutke
et al. 2014). Mice of all GH-transgenic genotypes (I//G,
I+//G, and G) consistently display significantly higher
glomerulosclerosis indices than non-GH-transgenic mice
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(I/, I+/, and I+/+ mice). Since glomerulosclerotic
lesions were exclusively observed in GH-transgenic mice,
these lesions must be regarded as a consequence of per-
manently and excessively elevated levels of GH (and GH-
dependent IGF1, if present). In contrast, the elevated
endogenous GH secretion with a pulsatile secretion pat-
tern that occurs as a feedback reaction to IGF1 deficiency
(Blutke et al. 2014) is apparently not sufficient to induce
development of comparable glomerular alterations in
(non-GH-transgenic) Igf1-knockout mice. Since I//G
mice and I+//G mice display significantly lower glomeru-
losclerosis indices than G mice (Blutke et al. 2014), IGF1
deficiency apparently slightly ameliorates the severity,
respectively, the velocity of progression of excess GH-
induced glomerulosclerosis in GH-transgenic mice. On
one hand, these findings indicate that excess GH-induced
IGF1 contributes to the development of glomerulosclero-
sis in GH-transgenic mice. On the other hand, although
the glomerulosclerosis indices in GH-transgenic mice
with intact igf1 alleles are significantly higher than in
IGF1-deficient mice, the present data also prove that GH
excess can cause glomerular and podocyte hypertrophy
sufficient to induce glomerulosclerosis, independently of
IGF1.
Indicating an excess GH-stimulated glomerular growth
even in the absence of IGF1, the relative mean glomerular
volumes of GH-overexpressing mice were on the average
three times as large as in sex-matched non-GH-transgenic
mice of identical Igf1 status, with male G mice exhibiting
the greatest average glomerular volume increase. Distinct
glomerular growth processes contributing to the enlarge-
ment of the glomerular tuft in GH-transgenic mice with
or without intact igf1 alleles were extensively characterized
by quantitative stereological analyses. Thus, glomerular
hypertrophy resulted from an increased mesangial volume
per glomerulus, hyperplasia of mesangial and endothelial
glomerular cells, a higher glomerular capillary volume
due to an increased capillary length per glomerulus, as
well as from hypertrophy of podocytes. G mice consis-
tently displayed the highest absolute magnitudes in the
different glomerular compartment- and cell-type growth
parameters, whereas the relative increases in these
parameters were in the same ranges in mice of all GH-
overexpressing genotypes, as compared to non-GH-trans-
genic mice of the same Igf1 status. Therefore, the relative
increase in the mean glomerular and podocyte volume in
GH-transgenic mice, as compared to non-GH-transgenic
mice of the same Igf1 status appears to be a critical step
in the development of glomerulosclerosis in GH-trans-
genic murine nephropathy models, rather than excess of a
distinct absolute glomerular or podocyte size.
Podocyte hypertrophy, as an initial step in the develop-
ment of podocyte damage subsequently leading to
glomerulosclerotic lesions, is regarded as a common reac-
tion of postmitotic podocytes to progressive glomerular
enlargement in diverse experimental nephropathy models
(Kretzler et al. 1994; Wolf and Wanke 1997; Wanke et al.
2001; Wiggins 2007). Additionally, it has been demon-
strated that podocyte hypertrophy can also precede
glomerular hypertrophy in murine models of diabetic
nephropathy (Herbach et al. 2009) and that the glomeru-
lar podocyte is a target of direct GH action (Reddy et al.
2007; Kumar et al. 2010, 2011). Given a probable contri-
bution of direct GH-mediated growth stimulation to
podocyte hypertrophy in the pathogenesis of glomeru-
losclerosis in GH-transgenic mice, the significantly
increased mean podocyte volumes in I//G versus I/
mice indicate that the growth stimulatory effect of excess
GH on podocytes can as well occur independently of
IGF1. However, the exact molecular pathways of potential
direct GH actions governing and modulating growth
responses of different renal/glomerular cell types in the
pathogenesis of glomerular hypertrophy and glomeru-
losclerosis will require further investigations. In parallel,
the finding that the highest increases of the mean
glomerular volume and of the mean podocyte volume
were observed in G versus I+/+ mice, confirms that excess
GH-induced IGF1 also substantially contributes to the
development of the pathogenetically relevant alterations
leading to glomerulosclerosis in GH-transgenic mice with
intact igf1 alleles.
In summary, the data presented in this study demon-
strate dissociated effects of GH and IGF1 in excess GH-
stimulated tubular and glomerular growth in vivo, and
indicate that (1) IGF1 is not necessary for mediation of
the effects of GH-overabundance causing progressive
glomerulosclerosis in GH-transgenic mice; and (2) IGF1
is an important mediator of excess GH-induced proximal
tubular hyperplasia. In light of the currently “reawaken”
interest in the role of GH in the pathogenesis of human
kidney diseases as diabetic nephropathy, and potentially
deducible therapeutic strategies for prevention and treat-
ment of these diseases (Kumar et al. 2011), the results of
the present study strongly encourage further investiga-
tions in this field.
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